← SynDRA
NIGULDIPINE
SynDRA canonical compound SYN0008993 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADRA1A |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
All known targets
- ADRA1A
- ADRA1B
- ADRA1D
- CACNA1C
Mechanisms of action (all sources)
- adrenergic receptor antagonist
- ADRA1B INHIBITOR
- CACNA1C INHIBITOR
- ADRA1D INHIBITOR
- ADRA1A INHIBITOR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ABCB1
- HRH1
- HTR1A
- HTR1B
- HTR1D
- HTR2B
- HTR2C
- HTR5A
- HTR6
- HTR7
- IFNG
- KCNK2
- MAPT
- OPRD1
- OPRK1
- OPRM1
- S1PR1
- SIGMAR1
- SLC6A2
- SLC6A3
- SLC6A4
- TMEM97
- TP53
- HRH3
- GPR65
- ADA1A
- GPR35
- ADA1B
- ADA1D
- ADORA3
- ADRA2A
- ADRA2B
- ADRA2C
- APLNR
- CHRM2
- CHRM3
- CHRM5
- CP2C9
- CP2CJ
- CP2D6
Drug classes
- Antihypertensive Agents
- Antineoplastic Agents
- Calcium Channel Blockers
Cross-references
Synonyms
- Niguldipino
- (+)-niguldipine
- S(+)-niguldipine
- UNII-Z81N45O25Z
- S(+)-Niguldipine hydrochloride
- Z81N45O25Z
- (+)-NIGULDIPINE
- Niguldipine [INN]
- niguldipine[inn]
- (S)-Niguldipine
- Tocris-1123
- Tocris-1124
- AC1Q1ZUF
- AC1L1TKT
- S(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(4,4-diphenyl-1-piperidinyl)-propyl methyl ester hydrochloride
- GTPL487
- SCHEMBL245992
- CHEMBL41929
- CHEMBL405355
- DTXSID60274008
- CHEBI:103931
- MFCD00873564
- BDBM50034683
- BDBM50453799
- ZINC100001967
- DB09239
- NCGC00025015-01
- BRD-K59333713
- niguldipine-(S)-(+)
- DNIG
- B859-35
- RefChem:854146
- 6Q39TPF0GL
- Niguldipinum
- NIGULDIPINE [WHO-DD]
- SCHEMBL29385244
- NCGC00025014-01
- NS00073175
Look up NIGULDIPINE in the interactive SynDRA portal →